19-18613914-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012109.3(TMEM59L):āc.214G>Cā(p.Val72Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012109.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM59L | NM_012109.3 | c.214G>C | p.Val72Leu | missense_variant | 2/8 | ENST00000262817.8 | NP_036241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM59L | ENST00000262817.8 | c.214G>C | p.Val72Leu | missense_variant | 2/8 | 1 | NM_012109.3 | ENSP00000262817 | P1 | |
TMEM59L | ENST00000594859.5 | n.300G>C | non_coding_transcript_exon_variant | 2/5 | 1 | |||||
TMEM59L | ENST00000600490.5 | c.214G>C | p.Val72Leu | missense_variant | 3/9 | 5 | ENSP00000470879 | P1 | ||
TMEM59L | ENST00000598660.1 | n.296G>C | non_coding_transcript_exon_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151892Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000817 AC: 2AN: 244796Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133046
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460272Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 726418
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.214G>C (p.V72L) alteration is located in exon 2 (coding exon 2) of the TMEM59L gene. This alteration results from a G to C substitution at nucleotide position 214, causing the valine (V) at amino acid position 72 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at